产品中心 抗体 其他一抗

所有图片(1/2)

β-TrCP Recombinant Rabbit mAb (S-3941-63)

F-box/WD repeat-containing protein 1A,E3RSIkappaB,Epididymis tissue protein Li 2a,F-box and WD repeats protein beta-TrCP,pIkappaBalpha-E3 receptor subunit,BTRCP,FBW1A,FBXW1A,BTRC

价格 600.00 供应商现货 : 3-5个工作日
货号 S0B6918
规格
数量
收藏 分享

产品介绍 评论(0)

产品规格
  • 宿主来源

    Rabbit
  • 抗原名称

    β-TrCP
  • 分子别名

    F-box/WD repeat-containing protein 1A; E3RSIkappaB; Epididymis tissue protein Li 2a; F-box and WD repeats protein beta-TrCP; pIkappaBalpha-E3 receptor subunit; BTRCP; FBW1A; FBXW1A; BTRC
  • 免疫原

    Synthetic Peptide
  • 细胞定位

    Nucleus, Cytoplasm
  • Accession

    Q9Y297
  • 克隆号

    S-3941-63
  • 抗体类型

    Recombinant mAb
  • 抗体同种型

    IgG
  • 反应种属 ?

    Hu, Mk
  • 阳性样本

    HepG2, HEK-293, COS-7
  • 纯化方式

    Protein A
  • 浓度

    2 mg/ml
  • 标记

    Unconjugated
  • 性状

    Liquid
  • 缓冲体系

    PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300

  • 储存条件

    12 months from date of receipt / reconstitution, -20 °C as supplied

  • 应用

    WB

  • 稀释度

    应用 稀释度 推荐种属
    WB 1:500-1:1000 Hu, Mk
背景介绍
  • β-TrCP (beta-transducin repeat-containing protein, also known as FBXW1 or BTRC) is a key F-box substrate recognition subunit of the SCF (SKP1-Cullin1-F-box) E3 ubiquitin ligase complex. Its core structure consists of multiple WD40 repeats that form a propeller-like beta-propeller structure, responsible for specifically recognizing and binding to the phosphorylated degron motif (typically "DSGxxS" or "DSGxxT," where the serine/threonine residues require pre-phosphorylation by kinases) in substrate proteins. Through this phosphorylation-dependent recognition mechanism, β-TrCP mediates the ubiquitination and subsequent degradation of various key signaling molecules—such as β-catenin, IκBα, Snail, Claspin, and CDC25A—thereby broadly regulating core signaling pathways including Wnt/β-catenin, NF-κB, Hedgehog, and cell cycle checkpoints. Physiologically, β-TrCP participates in maintaining normal cell cycle progression, DNA damage repair, cell polarity, and epithelial-mesenchymal transition (EMT). Pathologically, its aberrant expression or mutations are closely associated with the development and progression of various malignancies (such as colorectal cancer, breast cancer, and hepatocellular carcinoma). It can function as a tumor suppressor by degrading oncogenic proteins, but under certain circumstances, it may also promote cancer progression by degrading tumor suppressors, exhibiting its complex dual regulatory functions.

  • 免疫印迹

    • WB result of β-TrCP Recombinant Rabbit mAb
      Primary antibody: β-TrCP Recombinant Rabbit mAb at 1/1000 dilution
      Lane 1: HepG2 whole cell lysate 20 µg
      Lane 2: HEK-293 whole cell lysate 20 µg
      Secondary antibody: Goat Anti- rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
      Predicted MW: 69 kDa
      Observed MW: 62 kDa
      This blot was developed with high sensitivity substrate

    • WB result of β-TrCP Recombinant Rabbit mAb
      Primary antibody: β-TrCP Recombinant Rabbit mAb at 1/1000 dilution
      Lane 1: COS-7 whole cell lysate 20 µg
      Secondary antibody: Goat Anti- rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
      Predicted MW: 69 kDa
      Observed MW: 62 kDa
      This blot was developed with high sensitivity substrate

评论(0)